FibroGen Reports First Quarter 2024 Financial Results
May 06, 2024 16:02 ET
|
FibroGen, Inc.
Topline data from the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic cancer anticipated in mid-2024Topline data from LAPIS Phase 3 study in...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Plug Power Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PLUG
May 06, 2024 16:01 ET
|
The Rosen Law Firm PA
NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Plug Power Inc. (NASDAQ: PLUG) between May 9, 2023...
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 06, 2024 16:01 ET
|
Celldex Therapeutics, Inc.
- Phase 3 CSU studies expected to initiate in summer 2024 -- Positive Phase 2 CSU 12 week data reported in late breaking oral presentation at AAAAI 2024; 52 week data to be reported in 2H 2024 --...
Assertio Reports First Quarter 2024 Financial Results
May 06, 2024 16:01 ET
|
Assertio Holdings, Inc.
First Quarter Net Product Sales of $31.9 Million Rolvedon Growth Continues, with $14.5 million in Net Product Sales $7.5 Million in Cash Flow from Operations Increases Cash to...
SurgePays Announces First Quarter 2024 Earnings Release and Conference Call
May 06, 2024 16:01 ET
|
SurgePays, Inc.
BARTLETT, Tenn., May 06, 2024 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecommunications company focused on the underbanked and...
Travere Therapeutics Reports First Quarter 2024 Financial Results
May 06, 2024 16:01 ET
|
Travere Therapeutics, Inc.
FDA grants Priority Review for sNDA to convert FILSPARI® (sparsentan) from accelerated approval to full approval for the treatment of IgAN in the U.S.; PDUFA target action date of September 5, 2024 ...
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
May 06, 2024 16:01 ET
|
Corvus Pharmaceuticals, Inc.
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib Registration Phase 3 Trial in Peripheral T Cell...
CompoSecure Reports Record First Quarter 2024 Financial Results and Declares Special Cash Dividend
May 06, 2024 16:01 ET
|
CompoSecure, Inc.
Q1 Net Sales up 9% to $104.0 Million; Q1 Net Income up 59% to $17.1 Million; Q1 Adjusted EBITDA up 6% to $37.8 Million Declares Special Cash Dividend of $0.30 per Share SOMERSET, N.J., May 06, 2024...
FTC Solar to Announce First Quarter Financial Results Friday, May 10, 2024
May 06, 2024 16:01 ET
|
FTC Solar, Inc
AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, today announced it will report its...
Avetta Announces New Initiative for Rail Industry in Partnership with Australia’s Rail, Tram, and Bus Industry Union
May 06, 2024 16:00 ET
|
Avetta
NEWCASTLE, NSW, Australia, May 06, 2024 (GLOBE NEWSWIRE) -- Avetta®, the leading provider of Contractor Risk Management Software, today announced that the Australian Rail, Tram and Bus Industry...
- May 06, 2024 14:36 ET Pizza Nova opens its first location in Orangeville, Ontario
- May 06, 2024 13:07 ET Top Media Executives Launch Fixated To Redefine Digital Entertainment Standards For Creators, Fans And Brands